Scott Kelly said " We have requested a type c meeting with the FDA to gain further guidance with respect to completion of the BLA. Once we achieve the lift on clinical hold and receive further clarities from our type c meeting request from the FDA, we will be in better position to provide an updated timeline analysis."

So it sounds like it's been requested but who knows how long it takes for the FDA to set a date.